For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Vicarious Surgical Inc (NYSE: RBOT) closed at $2.69 up 8.03% from its previous closing price of $2.49. In other words, the price has increased by $8.03 from its previous closing price. On the day, 90510.0 shares were traded. RBOT stock price reached its highest trading level at $2.8193 during the session, while it also had its lowest trading level at $2.5516.
Ratios:
For a deeper understanding of Vicarious Surgical Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.75 and its Current Ratio is at 4.75. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.82.
Upgrades & Downgrades
In the most recent recommendation for the company, Piper Sandler on March 04, 2022, Downgraded its rating to Neutral and sets its target price to $7 from $16 previously.
On January 07, 2022, Credit Suisse started tracking the stock assigning a Outperform rating and target price of $16.
On December 07, 2021, Cowen started tracking the stock assigning a Outperform rating and target price of $15.Cowen initiated its Outperform rating on December 07, 2021, with a $15 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 20 ’25 when Khalifa Sammy sold 653 shares for $2.74 per share. The transaction valued at 1,792 led to the insider holds 33,862 shares of the business.
Sachs Adam David sold 816 shares of RBOT for $2,215 on Nov 20 ’25. The President now owns 48,348 shares after completing the transaction at $2.71 per share. On Nov 20 ’25, another insider, Adam Sachs, who serves as the Officer of the company, bought 816 shares for $2.81 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RBOT now has a Market Capitalization of 17614828 and an Enterprise Value of 17086828.
Stock Price History:
The Beta on a monthly basis for RBOT is 1.58, which has changed by -0.82201576 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, RBOT has reached a high of $19.00, while it has fallen to a 52-week low of $2.44. The 50-Day Moving Average of the stock is -47.20%, while the 200-Day Moving Average is calculated to be -63.69%.
Shares Statistics:
For the past three months, RBOT has traded an average of 79.87K shares per day and 93360 over the past ten days. A total of 5.31M shares are outstanding, with a floating share count of 3.60M. Insiders hold about 45.06% of the company’s shares, while institutions hold 9.53% stake in the company. Shares short for RBOT as of 1763078400 were 184088 with a Short Ratio of 2.30, compared to 1760486400 on 143315. Therefore, it implies a Short% of Shares Outstanding of 184088 and a Short% of Float of 4.3999999999999995.
Earnings Estimates
Investors are keenly observing as 3.0 analysts analyze and rate. The current performance of Vicarious Surgical Inc (RBOT) in the stock market.The consensus estimate for the next quarter is -$1.22, with high estimates of -$1.2 and low estimates of -$1.23.
Analysts are recommending an EPS of between -$7.94 and -$8.42 for the fiscal current year, implying an average EPS of -$8.15. EPS for the following year is -$4.52, with 3.0 analysts recommending between -$4.07 and -$4.94.
